Share：
Share this content in WeChat
X
[Chinese][PDF]78970
• Review •
Advances in imaging research of diabetes-related sarcopenia
LIU Baiyu  ZHA Yunfei 

Cite this article as: Liu BY, Zha YF. Advances in imaging research of diabetes-related sarcopenia. Chin J Magn Reson Imaging, 2019, 10(3): 232- 236. DOI:10.12015/issn.1674-8034.2019.03.015.


[Abstract] Sarcopenia is a geriatric syndrome characterized by the decline of skeletal muscle mass and function, and it is also one kind of chronic complications of diabetes mellitus which can lead to a series of adverse health consequences. Early identification of diabetes-related sarcopenia is of great significance in preventing disease progression and ensuring the quality of life, and imaging techniques have shown great clinical value for the evaluation of muscle mass change in the early stage of sarcopenia. This article mainly discusses the value and characteristics of different imaging techniques in the evaluation of diabetes-related sarcopenia.
[Keywords] sarcopenia；muscle fibers, skeletal；diabetes mellitus；diagnostic imaging

LIU Baiyu Department of Radiology, Renmin Hospital of Wuhan University, Wuhan 430060, China

ZHA Yunfei* Department of Radiology, Renmin Hospital of Wuhan University, Wuhan 430060, China; Hubei Key Laboratory of Medical Information Analysis and Tumor Diagnosis & Treatment, Wuhan 430074, Cnina

*Correspondence to: Zha YF, E-mail: zhayunfei999@126.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This work was part of National Natural Science Foundation of China No. 81871332 Opening Foundation of Hubei Key Laboratory of Medical Information Analysis and Tumor Diagnosis & Treatment No. PJS140011708
Received  2018-10-30
Accepted  2019-01-19
DOI: 10.12015/issn.1674-8034.2019.03.015
Cite this article as: Liu BY, Zha YF. Advances in imaging research of diabetes-related sarcopenia. Chin J Magn Reson Imaging, 2019, 10(3): 232- 236. DOI:10.12015/issn.1674-8034.2019.03.015.

[1]
Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc, 2014, 15(2): 95-101.
[2]
Lim S, Kwon SY, Yoon JW, et al. Association between body composition and pulmonary function in elderly people: the Korean Longitudinal Study on Health and Aging. Obesity (Silver Spring), 2011, 19(3): 631-638.
[3]
Sarodnik C, Bours S, Schaper NC, et al. The risks of sarcopenia, falls and fractures in patients with type 2 diabetes mellitus. Maturitas, 2018, 109: 70-77.
[4]
Tang TC, Hwang AC, Liu LK, et al. FNIH-defined sarcopenia predicts adverse outcomes among community-dwelling older people in Taiwan: results from I-Lan Longitudinal aging study. J Gerontol A Biol Sci Med Sci, 2018, 73(6): 828-834.
[5]
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working group on sarcopenia in older people. Age Ageing, 2010, 39(4): 412-423.
[6]
Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract, 2018, 138: 271-281.
[7]
Trierweiler H, Kisielewicz G, Hoffmann JT, et al. Sarcopenia: a chronic complication of type 2 diabetes mellitus. Diabetol Metab Syndr, 2018, 10: 25.
[8]
Bian AL, Hu HY, Rong YD, et al. A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-alpha. Eur J Med Res, 2017, 22(1): 25.
[9]
钟文，谢春光，高泓，等．糖尿病与肌少症关系研究新进展．中国糖尿病杂志, 2017, 25(7): 662-665.
[10]
Kim TN, Park MS, Yang SJ, et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean sarcopenic obesity study (KSOS). Diabetes Care, 2010, 33(7): 1497-1499.
[11]
Leenders M, Verdijk LB, van der Hoeven L, et al. Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. J Am Med Dir Assoc, 2013, 14(8): 585-592.
[12]
Moon SS. Low skeletal muscle mass is associated with insulin resistance, diabetes, and metabolic syndrome in the Korean population: the Korea national health and nutrition examination survey (KNHANES) 2009-2010. Endocr J, 2014, 61(1): 61-70.
[13]
Rolland Y, Czerwinski S, Abellan VK G, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging, 2008, 12(7): 433-450.
[14]
Bazzocchi A, Ponti F, Albisinni U, et al. DXA: technical aspects and application. Eur J Radiol, 2016, 85(8): 1481-1492.
[15]
Koo BK, Roh E, Yang YS, et al. Difference between old and young adults in contribution of beta-cell function and sarcopenia in developing diabetes mellitus. J Diabetes Investig, 2016, 7(2): 233-240.
[16]
Cheng Q, Hu J, Yang P, et al. Sarcopenia is independently associated with diabetic foot disease. Sci Rep, 2017, 7(1): 8372.
[17]
Heymsfield SB, Gonzalez MC, Lu J, et al. Skeletal muscle mass and quality: evolution of modern measurement concepts in the context of sarcopenia. Proc Nutr Soc, 2015, 74(4): 355-366.
[18]
Sergi G, Trevisan C, Veronese N, et al. Imaging of sarcopenia. Eur J Radiol, 2016, 85(8): 1519-1524.
[19]
Guerri S, Mercatelli D, Aparisi GM, et al. Quantitative imaging techniques for the assessment of osteoporosis and sarcopenia. Quant Imaging Med Surg, 2018, 8(1): 60-85.
[20]
Ross R. Advances in the application of imaging methods in applied and clinical physiology. Acta Diabetol, 2003, 40(Suppl 1): S45-S50.
[21]
van Vugt JL, Levolger S, de Bruin RW, et al. Systematic review and Meta-analysis of the impact of computed tomography-assessed skeletal muscle mass on outcome in patients awaiting or undergoing liver transplantation. Am J Transplant, 2016, 16(8): 2277-2292.
[22]
van der Werf A, Langius J, de van der Schueren M, et al. Percentiles for skeletal muscle index, area and radiation attenuation based on computed tomography imaging in a healthy Caucasian population. Eur J Clin Nutr, 2018, 72(2): 288-296.
[23]
Kim YK, Lee HS, Ryu JJ, et al. Sarcopenia increases the risk for mortality in patients who undergo amputation for diabetic foot. J Foot Ankle Res, 2018,11: 32.
[24]
Han SJ, Kim SK, Fujimoto WY, et al. Effects of combination of change in visceral fat and thigh muscle mass on the development of type 2 diabetes. Diabetes Res Clin Pract, 2017, 134: 131-138.
[25]
晏乘曦，唐光才，程晓光．肌少症的定量测量现状及研究进展．中国骨质疏松杂志, 2018, 24(6): 814-819.
[26]
Miljkovic I, Kuipers AL, Cvejkus R, et al. Myosteatosis increases with aging and is associated with incident diabetes in African ancestry men. Obesity (Silver Spring), 2016, 24(2): 476-482.
[27]
Butner KL, Creamer KW, Nickols-Richardson SM, et al. Fat and muscle indices assessed by pQCT: relationships with physical activity and type 2 diabetes risk. J Clin Densitom, 2012, 15(3): 355-361.
[28]
Erlandson MC, Lorbergs AL, Mathur S, et al. Muscle analysis using pQCT, DXA and MRI. Eur J Radiol, 2016, 85(8): 1505-1511.
[29]
Lustgarten MS, Fielding RA. Assessment of analytical methods used to measure changes in body composition in the elderly and recommendations for their use in phase II clinical trials. J Nutr Health Aging, 2011, 15(5): 368-375.
[30]
Boutin RD, Yao L, Canter RJ, et al. Sarcopenia: current concepts and imaging implications. AJR Am J Roentgenol, 2015, 205(3): W255-W266.
[31]
Delmonico MJ, Harris TB, Visser M, et al. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr, 2009, 90(6): 1579-1585.
[32]
Brons C, Grunnet LG. Mechanisms in endocrinology: skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes: a causal mechanism or an innocent bystander? Eur J Endocrinol, 2017, 176(2): R67-R78.
[33]
Kemmochi Y, Ohta T, Motohashi Y, et al. Pathophysiological analyses of skeletal muscle in obese type 2 diabetes SDT fatty rats. J Toxicol Pathol, 2018, 31(2): 113-123.
[34]
Kelley DE, Thaete FL, Troost F, et al. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab, 2000, 278(5): E941-E948.
[35]
Carlier PG, Marty B, Scheidegger O, et al. Skeletal muscle quantitative nuclear magnetic resonance imaging and spectroscopy as an outcome measure for clinical trials. J Neuromuscul Dis, 2016, 3(1): 1-28.
[36]
Ripley EM, Clarke GD, Hamidi V, et al. Reduced skeletal muscle phosphocreatine concentration in type 2 diabetic patients: a quantitative image-based phosphorus-31 MR spectroscopy study. Am J Physiol Endocrinol Metab, 2018, 315(2): E229-E239.
[37]
Bittel DC, Bittel AJ, Tuttle LJ, et al. Adipose tissue content, muscle performance and physical function in obese adults with type 2 diabetes mellitus and peripheral neuropathy. J Diabetes Complications, 2015, 29(2): 250-257.
[38]
Liu Y, Mei X, Li J, et al. Mitochondrial function assessed by 31P MRS and bold MRI in non-obese type 2 diabetic rats. Physiol Rep, 2016, 4(15 pii): e12890.
[39]
Berry DB, Regner B, Galinsky V, et al. Relationships between tissue microstructure and the diffusion tensor in simulated skeletal muscle. Magn Reson Med, 2018, 80(1): 317-329.
[40]
Buehler T, Bally L, Dokumaci AS, et al. Methodological and physiological test-retest reliability of (13) C-MRS glycogen measurements in liver and in skeletal muscle of patients with type 1 diabetes and matched healthy controls. NMR Biomed, 2016, 29(6): 796-805.
[41]
Ticinesi A, Meschi T, Narici MV, et al. Muscle ultrasound and sarcopenia in older individuals: a clinical perspective. J Am Med Dir Assoc, 2017, 18(4): 290-300.
[42]
Pillen S, van Alfen N. Skeletal muscle ultrasound. Neurol Res, 2011, 33(10): 1016-1024.
[43]
Ismail C, Zabal J, Hernandez HJ, et al. Diagnostic ultrasound estimates of muscle mass and muscle quality discriminate between women with and without sarcopenia. Front Physiol, 2015, 6: 302.
[44]
Worsley PR, Kitsell F, Samuel D, et al. Validity of measuring distal vastus medialis muscle using rehabilitative ultrasound imaging versus magnetic resonance imaging. Man Ther, 2014, 19(3): 259-263.
[45]
Morrison T, Jones S, Causby RS, et al. Can ultrasound measures of intrinsic foot muscles and plantar soft tissues predict future diabetes-related foot disease? A systematic review. PLoS One, 2018, 13(6): e199055.

PREV Research progresses in imaging of charcot neuropathic osteoarthropathy in diabetic foot
NEXT The latest development of multi-parametric magnetic resonance imaging assisted fusion puncture of prostate
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn